Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 17320513646 |
| E-mail: | mike@molcoo.com |
| QQ: | 3001071511 |
| Skype: | Chat Now! |
| Address: | Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China |
|
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
|
|
| Product Name | MF | CAS | Details |
|---|
| Desmopressin sulfoxide 1 | Details |
| Desmopressin sulfoxide 2 | Details |
| [β-Asp5]Desmopressin | Details |
| [Tyr2(3-OH)]-Desmopressin | Details |
| Carbetocin Asn breaking impurity 1 | Details |
| [disulphonic-acid]-Desmopressin | Details |
| Glu3-Carbetocin； | Details |
| βAsp5-Carbetocin | Details |
| [Des-Gly9]Desmopressin | Details |
| d-Asp eptifibatide | Details |
| Carbetocin Sulfoxide I; Carbetocin S-Oxide I;Carbetocin impurity; | C45H69N11O13S | 221464-32-0 | Details |
| Felypressin EP Impurity B; Asp5 Felypressin | Details |
| Carbetocin Sulfoxide II; Carbetocin impurity; | Details |
| Carbetocin Impurity 39 | C45H68N10O13S | 1352167-71-5 | Details |
| Difelikefalin impurity 11 Trifluoroacetate | Details |
| D-Ile-Difelikefalin | Details |
| Felypressin EP Impurity F; Glu4 Felypressin | Details |
| Difelikefalin dimer | Details |
| Difelikefalin impurity 24 | Details |
| d-Pro eptifibatide | Details |
| Difelikefalin impurity 3 Trifluoroacetate | C21H31N3O4 | Details |
| Di-Trp-Eptifibatide | Details |
| Atosiban impurity 11;Gly-ol Atosiban | Details |
| D-Asn5-Carbetocin | C45H69N11O12S | 1631754-27-2 | Details |
| Carbetocin Asn breaking impurity 4 | Details |
| Eptifibatide impurity Y; Des-Gly3 eptifibatide | Details |
| Difelikefalin impurity 4 Trifluoroacetate | C21H31N3O4 | Details |
| Difelikefalin impurity 19 | Details |
| D-Har Lecirelin | Details |
| Atosiban Z44;Asp5 Atosiban | Details |
| Des-Mpr-Harg Eptifibatide | Details |
| Atosiban Z1;Des-Gly Atosiban | Details |
| MeOH Trp-Eptifibatide；Trp(CH2OH)-Eptifibatide | C36H51N11O10S2 | Details |
| DTrp-Eptifibatide | Details |
| Eptifibatide Trisulfide | Details |
| Lys4-Difelikefalin | Details |
| [D-Pal3(PA)]-Ganirelix | Details |
| Des-Pro-Eptifibatide | Details |
| Atosiban impurity C;Des-Gly-NH2 Atosiban | Details |
| Reduced eptifibatide | C35H51N11O9S2 | 135900-78-6 | Details |
| Vasopressin Dimer (parallel) | Details |
| Difelikefalin impurity 12 Trifluoroacetate | Details |
| Difelikefalin impurity 5 Trifluoroacetate | C37H55N7O6 | 1024828-78-1 | Details |
| Atosiban Z9,Gly9 Atosiban | C43H66N10O13S2 | 168102-69-0 | Details |
| Argipressin Dimer(Antiparallel) | Details |
| Eptifibatide Dimer(unparallel) | Details |
| Carbetocin Asn breaking impurity 3 | Details |
| Difelikefalin impurity 10 | C37H55N7O6 | 2756592-19-3 | Details |
| Carbetocin Asn breaking impurity 2 | Details |
| Tle6 GnRH; Tle6 Gonadotropin-Releasing Hormone | Details |
| Atosiban impurity 16;Val3 Atosiban | Details |
| Difelikefalin impurity 13 Trifluoroacetate | Details |
| Vas-Ac-Argipressin | Details |
| Atosiban Dimer(parallel) | Details |
| Deamidated Eptifibatide； Deamidated(Eptifibatide acid) | C35H48N10O10S2 | 618118-95-9 | Details |
| Di-Gly-Argipressin | C48H67N15O14S2 | 114665-05-3 | Details |
| Difelikefalin impurity 16 | Details |
| Difelikefalin impurity 7 Trifluoroacetate | C20H27N3O4 | Details |
| Atosiban impurity D;Orn(Ac) Atosiban | Details |
| Des-Trp-Eptifibatide | Details |
| Asp5-Argipressin | C46H64N14O13S2 | 78031-79-5 | Details |
| Difelikefalin impurity 9 Trifluoroacetate | C39H59N7O6 | Details |
| Adipokinetic Hormone II Locusta Migratoria | C43H57N11O11 | 98968-94-6 | Details |
| Atosiban impurity E;Cyclo(Orn) Atosiban | Details |
| Difelikefalin impurity 1 Trifluoroacetate | C20H29N3O4 | Details |
| ACTH (11-24) | C77H134N24O16 | 4237-93-8 | Details |
| ACTH (1-16), human | C89H133N25O22S | 5576-42-1 | Details |
| Atosiban impurity F；linear Atosiban | Details |
| ACTH (1-13), human | C75H106N20O19S | 22006-64-0 | Details |
| Difelikefalin impurity 26 | Details |
| Difelikefalin impurity 15 | Details |
| Difelikefalin impurity 2 Trifluoroacetate | C21H32ClN3O4 | Details |
| β-Asp-Eptifibatide | Details |
| ACTH(1-39),human | C210H314N56O57S | 9061-27-2 | Details |
| Gly double addition eptifibatide；Eptifibatide Impurity 19 | C37H52N12O10S2 | 868242-25-5 | Details |
| Difelikefalin impurity | C36H53N7O6 | 2742623-84-1 | Details |
| DCys-Eptifibatide | Details |
| ACTH (1-4) | C20H30N4O8S | 19405-50-6 | Details |
| Pasireotide dimer | Details |
| N-Nitroso Mirabegron | Details |
| Difelikefalin impurity 20 | Details |
| Felypressin EP Impurity A;S1,S6-bis[(acetylamino)methyl]-(reduced felypressin) | Details |
| ACTH (7- 38), human | C167H257N47O46 | 68563-24-6 | Details |
| Benazepril Enantiomer HCl | C24H28N2O5 | Details |
| Eptifibatide Dimer(parallel) | Details |
| 4-10-Ganirelix | C48H84N14O9 | 129225-23-6 | Details |
| [Glu10] - ACTH (1 - 17) | C95H145N29O23S | 7266-47-9 | Details |
| Pitavastatin(Phenylethylamine Salt) | Details |
| Adipokinetic Hormone, G (AKH-G) | C43H57N11O12 | 113800-65-0 | Details |
| Di-Pro-Eptifibatide | Details |
| ACTH (1-39), rat | C210H315N57O57S1 | 77465-10-2 | Details |
| Asp-Clipped Eptifibatide | C35H51N11O10S2 | 358620-99-2 | Details |
| Atosiban Z14;Di-Gly Atosiban | Details |
| ACTH?(2-24) | C133H205N39O29S | 67654-32-4 | Details |
| Citalopram EP Impurity F | C19H21BrFNO | 64169-39-7 | Details |
| Myelin Oligodendrocyte Glycoprotein(35-55), rat MOG(35-55) | C118H177N35O29S | 149635-73-4 | Details |
| Difelikefalin impurity 6 | C24H30ClN3O4 | 1281870-04-9 | Details |
| ACTH (18-39), human | C112H165N27O36 | 53917-42-3 | Details |
| Felypressin EP Impurity E; N1-acetylfelypressin | Details |
| ACTH (3-24), human | C124H196N38O27S | 1036763-00-4 | Details |
| Product Total： Product Page： | ||||
| 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 | ||||